相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Ju-Hee Kang et al.
ACTA NEUROPATHOLOGICA (2016)
The utility of -synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Anja Hviid Simonsen et al.
BIOMARKERS IN MEDICINE (2016)
Value of cerebrospinal fluid -synuclein species as biomarker in Parkinson's diagnosis and prognosis
Lucilla Parnetti et al.
BIOMARKERS IN MEDICINE (2016)
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
Maria Bjerke et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
Hugo Marcel Johan Vanderstichele et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Brit Mollenhauer et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies
Franc Llorens et al.
JOURNAL OF NEUROLOGY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
Paolo Eusebi et al.
BMJ OPEN (2016)
Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
Nathalie Le Bastard et al.
CLINICAL CHEMISTRY (2015)
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
N. K. Magdalinou et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Parkinson's Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
Michael Lawton et al.
JOURNAL OF PARKINSONS DISEASE (2015)
New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression A Prospective Cohort Comparison With Other Phenotypes
Seyed-Mohammad Fereshtehnejad et al.
JAMA NEUROLOGY (2015)
Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease
Yaroslau Compta et al.
JOURNAL OF NEUROLOGY (2015)
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleo et al.
NATURE REVIEWS NEUROLOGY (2015)
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference
Ryotaro Ishii et al.
PLOS ONE (2015)
The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Jose Luis Molinuevo et al.
ALZHEIMERS & DEMENTIA (2014)
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
Sylvain Lehmann et al.
ALZHEIMERS & DEMENTIA (2014)
Reduced Alpha-Synuclein in Cerebrospinal Fluid in Synucleinopathies: Evidence From a Meta-analysis
Wataru Sako et al.
MOVEMENT DISORDERS (2014)
Submandibular gland needle biopsy for the diagnosis of Parkinson disease
Charles H. Adler et al.
NEUROLOGY (2014)
Low clinical diagnostic accuracy of early vs advanced Parkinson disease Clinicopathologic study
Charles H. Adler et al.
NEUROLOGY (2014)
Alpha synuclein is transported into and out of the brain by the blood-brain barrier
Yu-Ting Sui et al.
PEPTIDES (2014)
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Protein instability following transport or storage on dry ice
Brian M. Murphy et al.
NATURE METHODS (2013)
Sleep Drives Metabolite Clearance from the Adult Brain
Lulu Xie et al.
SCIENCE (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
Sara Hall et al.
ARCHIVES OF NEUROLOGY (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system
Brit Mollenhauer et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Cerebrospinal fluid and lumbar puncture: a practical review
Ben L. C. Wright et al.
JOURNAL OF NEUROLOGY (2012)
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
Ivana Devic et al.
BRAIN (2011)
Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies
Marie-Anne Valentin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease
Kelly Del Tredici et al.
ACTA NEUROPATHOLOGICA (2010)
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects
John Q. Trojanowski et al.
ALZHEIMERS & DEMENTIA (2010)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20
Arnaldo M. Pica-Mendez et al.
CLINICA CHIMICA ACTA (2010)
Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients
Henrik Zetterberg et al.
EUROPEAN NEUROLOGY (2010)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment
Raquel Duran et al.
MOVEMENT DISORDERS (2010)
Neuropothological assessment of Parkinson's disease: refining the diagnostic criteria. (vol 8, pg 1150, 2009)
D. W. Dickson et al.
LANCET NEUROLOGY (2010)
The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)
Therese Rosenling et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Dennis W. Dickson et al.
LANCET NEUROLOGY (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Endogeneous peptide profiling of cerebrospinal fluid by MALDI-TOF mass spectrometry: Optimization of magnetic bead-based peptide capture and analysis of preanalytical variables
Connie R. Jimenez et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Plasma α-synuclein is decreased in subjects with Parkinson's disease
Qiao-Xin Li et al.
EXPERIMENTAL NEUROLOGY (2007)
Fluctuations of CSF amyloid-β levels -: Implications for a diagnostic and therapeutic biomarker
Randall J. Bateman et al.
NEUROLOGY (2007)
Protein stability during freezing: Separation of stresses and mechanisms of protein stabilization
Bakul S. Bhatnagar et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2007)
Determination of alpha-synuclein concentration in human plasma using ELISA
A. Winther Fjorback et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2007)
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease
Takahiko Tokuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy
P. H. Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat
Eric Murillo-Rodniguez et al.
LIFE SCIENCES (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides
P Lewczuk et al.
CLINICAL CHEMISTRY (2006)
Sample handling for mass spectrometric proteomic investigations of human sera
M West-Hielsen et al.
ANALYTICAL CHEMISTRY (2005)
The five-parameter logistic: A characterization and comparison with the four-parameter logistic
PG Gottschalk et al.
ANALYTICAL BIOCHEMISTRY (2005)
The impact of blood contamination on the proteome of cerebrospinal fluid
JS You et al.
PROTEOMICS (2005)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Dopamine receptor immunohistochemistry in the rat choroid plexus
F Mignini et al.
JOURNAL OF AUTONOMIC PHARMACOLOGY (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
